Factors associated with 5-year survival of combined hepatocellular and cholangiocarcinoma

Table 2 Univariate and multivariate logistic regression for 5-year survival

	Univariate analysis		Multivariate analysis
	OR [95%CI]	P value	OR [95%CI]	P value
Age > 60 yr old	0.372 [0.195-0.708]1	< 0.01	0.502 [0.231-1.088]	0.08
Sex (Male)	1.604 [0.774-3.323]	0.20	1.264 [0.537-2.975]	0.59
Race		0.13		0.07
Black	0.432 [0.099-1.888]		0.483 [0.095-2.444]
Hispanic	1.275 [0.547-2.976]		2.043 [0.744-5.613]
API	2.014 [0.971-4.176]		2.793 [1.120-6.967]1
AJCC stages				0.41
Stage I/II vs unknown	8.143 [1.913-34.660]1	< 0.01	1.048 [0.185-5.935]
Stage III/IV vs unknown	1.024 [0.202-5.186]	0.06	0.498 [0.074-3.328]
Stage I /II vs III/IV	7.954 [3.284-19.264]1	< 0.01
Metastasis	0.057 [0.008-0.416]1	< 0.01	0.602 [0.059-6.165]	0.67
Tumor size < 50 mm	6.098 [3.067-12.200]1	< 0.01	2.415 [1.010-5.780]1	0.05
LRT	0.884 [0.201-3.886]	0.87	4.622 [0.671-31.856]	0.12
Resection	3.017 [1.620-5.620]1	< 0.01	12.849 [3.359-49.142]1	< 0.01
Transplant	10.769 [5.398-21.485]1	< 0.01	28.129 [6.639-119.187]1	< 0.01

¹Significant confidence interval.

White as a comparison group for race. AJCC: American Joint Committee on Cancer; API: Asians and Pacific Islanders; LRT: Locoregional therapy; OR: Odds ratio.